Josef H. von Rickenbach
Chairman
Rein Therapeutics, Inc. (RNTX)Board Member
Rein Therapeutics, Inc. (RNTX)Personal wealth note: Equibles reports source-backed professional activity and disclosed compensation; it does not estimate personal net worth.
About Josef H. von Rickenbach
Josef H. von Rickenbach is recorded as Chairman and Board Member at Rein Therapeutics, Inc. (RNTX). Rein Therapeutics, Inc. reported in an 8-K filed February 29, 2024 that Josef H. von Rickenbach was appointed Class III director, effective February 28, 2024.
“The stockholders of the Company elected Manuel C. Alves-Aivado, M.D., Ph.D., Reinhard Ambros, Ph.D., and Josef H. von Rickenbach as Class III directors for a three-year term expiring at the 2026 annual meeting of stockholders.”
Summary generated from SEC filings and earnings-call records held by Equibles.
Affiliation history
Recorded current and former roles; source labels appear when available.
-
Current
2024-02-29–present
-
Current
Start not stated–present
Company network
Recorded roles and call appearances connecting this person to public companies.
Leadership on record at Rein Therapeutics, Inc.
Other people whose current roles at this company are on record from its filings.
- Brian Windsor CEO, COO, Board Member
- Brian Windsor, Ph.D. CEO, COO, Board Member
- Charles Garner CFO
- Donald V. Dougherty CFO
- Timothy M. Cunningham CFO
- Manuel Aivado Chief Accounting Officer
- Alan A. Musso Board Member
- Manuel C. Alves-Aivado, M.D., Ph.D. Board Member
- Reinhard Ambros, Ph.D. Board Member
- Reinhard J. Ambros Board Member
Recent activity
Earnings-call and investor-event appearances, plus filed executive appointments or departures, newest first.